Novo Nordisk Recalls Fiasp Insulin Samples Due to Temperature Abuse
Novo Nordisk is recalling Fiasp (insulin aspart injection) samples stored below 32°F, which may cause lack of efficacy and damage to the cartridge and pen-injectors.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 4 per the rubric, as Class I recalls involve a reasonable probability of serious adverse health consequences or death.
Plain-English summary
Novo Nordisk Inc is recalling Fiasp (insulin aspart injection), 100 units/mL (U-100), One 10 mL multi-dose vial, Sample. The affected products are identified by lot codes KS6BX63 (exp 10/31/2022), KS6AK76 (exp 05/31/2022), and KS6BR92 (exp 09/30/2022). The recall is due to temperature abuse, as the product samples were stored at temperatures below 32°F, which is not in accordance with storage requirements.
This temperature deviation could cause a lack of efficacy and damage to the cartridge and pen-injectors. The affected products were distributed nationwide in the USA. The source text does not specify the number of units recalled or report any illnesses or injuries associated with this recall.
Consumers and healthcare providers should check their inventory for the specific lot codes and expiration dates listed above. If these products are found, they should be stopped from use and returned to the distributor or manufacturer in accordance with standard recall procedures.
The recalled product
- Product
- FIASP (INSULIN ASPART INJECTION)
- Brand
- FIASP
- Manufacturer
- Novo Nordisk Inc
- Category
- Drug — Insulin
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- KS6BX63 exp 10/31/2022
- KS6AK76 exp 05/31/2022
- KS6BR92 exp 09/30/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 13 recalled by Novo Nordisk Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same brand · FIASP
- SevereNovo Nordisk Recalls Fiasp Insulin Pens Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
- SevereNovo Nordisk Recalls Fiasp Insulin Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
Same manufacturer · Novo Nordisk Inc
See all →- HighWegovy 0.5 mg pens recalled after hair was found in a syringe
FDA (Drugs) · 2026-01-07
- HighWegovy prefilled pens recalled after hair was found in a syringe
FDA (Drugs) · 2026-01-07
- ModerateNovo Nordisk Recalls OZEMPIC Injection Pens Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
- SevereNovo Nordisk Recalls TRESIBA Insulin Pens Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
- SevereNovo Nordisk Recalls Insulin Diluting Medium Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
Same hazard · lack of efficacy
See all →- SevereNovo Nordisk Recalls TRESIBA Insulin Samples Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
- ModerateNovo Nordisk Recalls Victoza Injection Due to Temperature Abuse
FDA (Drugs) · 2021-04-21
- ModerateNovo Nordisk Recalls Saxenda Injection Samples Due to Temperature Abuse
FDA (Drugs) · 2021-04-21